Our epidemiological results support the causal relationship between low ApoA1 as an independent risk factor of infection by SARS-CoV-2 in NAFLD patients with additive risks of T2DM and obesity [2,3,4,5,6,7,8,9,10,13,91]. Here, APOA1 is linked to metabolic dysfunction-associated steatotic liver disease.